Get startedLog in
    Picture of Sun Pharma Advanced Research logo

    SPARC — Sun Pharma Advanced Research News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    All News

    Brief: Sun Pharma Advanced Research Company Says U.S. FDA Grants Orphan Drug Designation To Phenobarbital

    Picture of Sun Pharma Advanced Research logoSun Pharma Advanced Research
    04/10/2019 14:39
    Oct 4 (Reuters) - Sun Pharma Advanced Research Company Ltd
 SPRC.NS :
    * SUN PHARMA ADVANCED RESEARCH COMPANY LTD - U.S. FDA GRANTS
ORPHAN DRUG DESIGNATION TO PHENOBARBITAL FOR TREATMENT OF
PATIENTS WITH NEONATAL SEIZURES

Source text for Eikon:  ID:nBSEGl7RD 
Further company coverage:  SPRC.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Sun Pharma Advanced Research

    See all news